Connective tissue disorders Archives - Page 3 of 5 - Hospital Healthcare EuropeHospital Healthcare Europe

This website is intended for healthcare professionals only.

Connective tissue disorders

Inhibiting cancer-causing protein could prevent scleroderma fibrosis

Inhibiting cancer-causing protein could prevent scleroderma fibrosis

Study shows that lupus is strongly linked to imbalances in gut microbiome

Study shows that lupus is strongly linked to imbalances in gut microbiome

Expert view: Immunosenescence vs autoimmunity

Expert view: Immunosenescence vs autoimmunity

NOVESA Phase IIa trial in patients with systemic sclerosis initiated

NOVESA Phase IIa trial in patients with systemic sclerosis initiated

Scientists recognised for transformative lupus research projects

Scientists recognised for transformative lupus research projects

Expert analysis: Challenges in diagnosing connective tissue diseases

Expert analysis: Challenges in diagnosing connective tissue diseases

Expert view: Ustekinumab for SLE?

Expert view: Ustekinumab for SLE?

Expert analysis: The importance of serological markers and serodiagnostics in RA

Expert analysis: The importance of serological markers and serodiagnostics in RA

Optimising management of systemic lupus erythematosus

International updates and 2017 criteria of the Ehlers-Danlos syndromes

Novel treatments in the management of myositis

Monoclonal antibody shows positive results in treatment of SLE in Phase II trial

Monoclonal antibody shows positive results in treatment of SLE in Phase II trial

Supporting awareness of Viking disease

Supporting awareness of Viking disease

Orphan drug designation granted to nintedanib for treatment of systemic sclerosis

Orphan drug designation granted to nintedanib for treatment of systemic sclerosis

NICE recommends GSK’s Benlysta® (belimumab) for lupus

NICE recommends GSK’s Benlysta® (belimumab) for lupus